Skip to content
Screener

Insmed INSM Reportable Segment — Intangible Amortization

Similar metrics at other companies

BellRing Brands logo
BRBRReportable Segment — Intangible Amortization
$4.2M0.0%
Powell Industries logo
POWLReportable Segment — Intangible Amortization
$223K
TaskUs logo
TASKReportable Segment — Intangible Amortization
$5M+0.1%
Citizens Community Bancorp logo
CZWIReportable Segment — Intangible Amortization
$113K-36.9%
Pacific Biosciences of California logo
PACBReportable Segment — Intangible Amortization
$833K0.0%
Claritev Corporation logo
CTEVReportable Segment — Intangible Amortization
$85.91M-0.1%

Other financials

Income statement

See full
Revenue$425.5M+296%
Gross profit$358.3M+352%
Operating income-$1.5M+99.5%
Net income-$13.2M+95.9%
EPS (diluted)-$0.06+96.5%

Balance sheet

See full
Cash & equivalents$544.8M-57.6%
Total debt$579.9M+0.8%
Total equity$757.5M-39.4%
Total assets$2.1B-15.2%

Cash flow

See full
Operating cash flow-$88.8M+56.8%
CapEx$6.3M+79.6%
Free cash flow-$95.1M+54.5%

Valuation

See full
Market cap$21.46B+1.6%
Enterprise value$21.5B+5.3%
P/S18.9×-34.2×

Profitability

See full
Gross margin83.5%+7.7pp
Operating margin-73.9%-30.6pp
Net margin-76.9%-31.8pp
FCF margin-71%-28.6pp

Returns & leverage

See full
Return on equity-87.2%-27.3pp
Debt / equity0.8×+0.3×
Current ratio3.7×-3.0×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: Insmed’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:59 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104506-26-000041
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
SG&A compensation and benefit-related expenses70,52051,320145,313106,156
Other segment items(a)207,425127,650417,913247,345
Depreciation3,1792,4846,1134,367
Amortization of intangible assets2,0811,2634,1622,526
Change in fair value of contingent consideration(99,760)59,000(146,721)77,300
Investment income(10,979)(13,225)(23,019)(27,131)
Interest expense20,27321,24540,35542,814
Provision for income taxes1,8691,2433,3342,155

Item 1C. Consolidated Financial Statements

FAQ

What is Insmed's reportable segment — intangible amortization?
Insmed (INSM) reported reportable segment — intangible amortization of $2.08M in Q2 2026.
How has Insmed's reportable segment — intangible amortization changed year-over-year?
Insmed's reportable segment — intangible amortization increased by 64.8% year-over-year, from $1.26M to $2.08M.
What is the long-term trend for Insmed's reportable segment — intangible amortization?
Over 3 years (2022 to 2025), Insmed's reportable segment — intangible amortization has grown at a 5.9% compound annual growth rate (CAGR), from $5.05M to $6M.
What does reportable segment — intangible amortization mean?
This is the non-cash expense related to the write-down of acquired intangible assets, such as patents or licenses. It reflects the consumption of the economic value of acquired intellectual property.

Ask your AI about Insmed's reportable segment — intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude